Latest Metformin Stories
Results from Phase 2b Clinical Study in Patients with Type 2 Diabetes Provide Evidence that SGLT1 inhibition with LX4211 Provides a Clinically Meaningful Benefit THE WOODLANDS, Texas,
A recently-published literature review reveals that people with prediabetes have a 15 percent higher risk of developing cancer — and the level of risk differs depending on the type of cancer.
No overall statistically significant increased risk of bladder cancer in patients ever exposed to pioglitazone in a completed 10-year epidemiological study OSAKA, Japan, Aug.
A large-scale study from Cardiff University reveals that people with Type 2 diabetes can live longer than those without the condition, thanks to a widely prescribed blood glucose control medication.
In Phase 3 studies, INVOKANA® plus metformin lowered blood sugar and reduced secondary endpoints of body weight and systolic blood pressure to a greater degree than metformin alone RARITAN,
Metformin and SGLT2 inhibitors together reduce the blood sugar levels considerably more effectively than either drug alone.
- Combination of linagliptin and metformin significantly reduced blood glucose levels compared with linagliptin alone RIDGEFIELD, Conn. and INDIANAPOLIS, Aug.
LONDON, July 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Labeling people with moderately high blood sugar as pre-diabetic is a drastically premature measure with no medical value and huge financial and social costs
--Microbiome Modulator NM504 Significantly Improved Blood Glucose Control and Other Metabolic Parameters in Patients with Prediabetes and Type 2 Diabetes-- CHICAGO and BROOMFIELD,
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.